High-Cost Generic Drugs — Implications for Patients and Policymakers

Jonathan D. Alpern, William M. Stauffer, Aaron S. Kesselheim

New England Journal of Medicine · 2014 · 103 citations · 1 references

Concepts

Abstract

Some older generic drugs have become very expensive, owing to factors including drug shortages, supply disruptions, and consolidations in the generic-drug industry. But generics manufacturers that legally obtain a market monopoly can also unilaterally raise prices.

References

1